Published in PLoS One on June 30, 2014
Increased levels of inflammatory cytokines in the female reproductive tract are associated with altered expression of proteases, mucosal barrier proteins, and an influx of HIV-susceptible target cells. Mucosal Immunol (2015) 1.03
Human beta-defensins 2 and -3 cointernalize with human immunodeficiency virus via heparan sulfate proteoglycans and reduce infectivity of intracellular virions in tonsil epithelial cells. Virology (2015) 0.80
Rectal 1% Tenofovir Gel Use Associates with Altered Epidermal Protein Expression. AIDS Res Hum Retroviruses (2016) 0.76
Periluminal Distribution of HIV-Binding Target Cells and Gp340 in the Oral, Cervical and Sigmoid/Rectal Mucosae: A Mapping Study. PLoS One (2015) 0.75
Cystatin B and HIV regulate the STAT-1 signaling circuit in HIV-infected and INF-β-treated human macrophages. J Neurovirol (2016) 0.75
Recent 5-year Findings and Technological Advances in the Proteomic Study of HIV-associated Disorders. Genomics Proteomics Bioinformatics (2017) 0.75
Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy. Antimicrob Agents Chemother (2002) 13.91
Effects of CCR5 and CD4 cell surface concentrations on infections by macrophagetropic isolates of human immunodeficiency virus type 1. J Virol (1998) 10.94
Beta-defensins: linking innate and adaptive immunity through dendritic and T cell CCR6. Science (1999) 7.86
HIV transmission risk through anal intercourse: systematic review, meta-analysis and implications for HIV prevention. Int J Epidemiol (2010) 7.72
Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection. J Exp Med (2009) 7.01
Sensitivity of human immunodeficiency virus type 1 to the fusion inhibitor T-20 is modulated by coreceptor specificity defined by the V3 loop of gp120. J Virol (2000) 6.71
Serpin structure, mechanism, and function. Chem Rev (2002) 5.39
Inhibiting sexual transmission of HIV-1 infection. Nat Rev Microbiol (2003) 5.29
Cathelicidins, multifunctional peptides of the innate immunity. J Leukoc Biol (2003) 3.56
Secretory leukocyte protease inhibitor: a human saliva protein exhibiting anti-human immunodeficiency virus 1 activity in vitro. J Clin Invest (1995) 2.95
Host resistance factors in human milk. J Pediatr (1973) 2.69
HIV-neutralizing immunoglobulin A and HIV-specific proliferation are independently associated with reduced HIV acquisition in Kenyan sex workers. AIDS (2008) 2.67
Human epithelial beta-defensins 2 and 3 inhibit HIV-1 replication. AIDS (2003) 2.55
Oral sex and the transmission of viral STIs. Sex Transm Infect (1998) 2.50
Structure, function, and membrane integration of defensins. Curr Opin Struct Biol (1995) 2.40
The function of immunoglobulin A in immunity. J Pathol (2006) 2.31
Identification of gammaretroviruses constitutively released from cell lines used for human immunodeficiency virus research. J Virol (2008) 2.27
Secretory IgA's complex roles in immunity and mucosal homeostasis in the gut. Mucosal Immunol (2011) 2.26
Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide. Cell (2007) 2.22
Antiviral effects of plasma and milk proteins: lactoferrin shows potent activity against both human immunodeficiency virus and human cytomegalovirus replication in vitro. J Infect Dis (1995) 2.16
Secretory leukocyte protease inhibitor binds to annexin II, a cofactor for macrophage HIV-1 infection. J Exp Med (2004) 2.05
Interaction of antigens and antibodies at mucosal surfaces. Annu Rev Microbiol (1997) 2.02
SLPI and elafin: one glove, many fingers. Clin Sci (Lond) (2006) 1.84
Epithelial antimicrobial peptides: review and significance for oral applications. Crit Rev Oral Biol Med (1998) 1.71
Mucosal and plasma IgA from HIV-1-exposed uninfected individuals inhibit HIV-1 transcytosis across human epithelial cells. J Immunol (2000) 1.69
Levels of innate immune factors in genital fluids: association of alpha defensins and LL-37 with genital infections and increased HIV acquisition. AIDS (2009) 1.64
Evidence that ecotropic murine leukemia virus contamination in TZM-bl cells does not affect the outcome of neutralizing antibody assays with human immunodeficiency virus type 1. J Virol (2009) 1.61
Antimicrobial peptide LL-37 produced by HSV-2-infected keratinocytes enhances HIV infection of Langerhans cells. Cell Host Microbe (2013) 1.56
Alpha-1-antitrypsin inhibits human immunodeficiency virus type 1. FASEB J (2001) 1.50
Parotid salivary basic proline-rich proteins inhibit HIV-I infectivity. Oral Dis (2001) 1.48
Cross-clade HIV-1-specific neutralizing IgA in mucosal and systemic compartments of HIV-1-exposed, persistently seronegative subjects. J Acquir Immune Defic Syndr (2002) 1.45
Elafin (elastase-specific inhibitor) has anti-microbial activity against gram-positive and gram-negative respiratory pathogens. FEBS Lett (1999) 1.41
Apolipoproteins modulate the inflammatory response to lipopolysaccharide. J Endotoxin Res (2005) 1.39
Oral transmission of HIV, reality or fiction? An update. Oral Dis (2006) 1.38
Serine proteases of the human immune system in health and disease. Mol Immunol (2010) 1.30
Lactoferrin and transferrin damage of the gram-negative outer membrane is modulated by Ca2+ and Mg2+. J Gen Microbiol (1990) 1.28
Systematic review of orogenital HIV-1 transmission probabilities. Int J Epidemiol (2008) 1.28
The role of cystatins in cells of the immune system. FEBS Lett (2006) 1.24
Induction of SLPI (ALP/HUSI-I) in epidermal keratinocytes. J Invest Dermatol (1998) 1.24
Endogenous mucosal antiviral factors of the oral cavity. J Infect Dis (1999) 1.18
Alpha-defensins block the early steps of HIV-1 infection: interference with the binding of gp120 to CD4. Blood (2007) 1.16
Inhibitory effect of HIV-specific neutralizing IgA on mucosal transmission of HIV in humanized mice. Blood (2012) 1.11
In vitro inhibition of HIV-1 infectivity by human salivas. AIDS Res Hum Retroviruses (1990) 1.09
Innate and adaptive anti-HIV immune responses in the female reproductive tract. J Reprod Immunol (2013) 1.09
Inhibition of early steps in the lentiviral replication cycle by cathelicidin host defense peptides. Retrovirology (2005) 1.07
Chemokines as natural HIV antagonists. Curr Mol Med (2002) 1.05
Human defensins 5 and 6 enhance HIV-1 infectivity through promoting HIV attachment. Retrovirology (2011) 1.04
MUC1 and MUC13 differentially regulate epithelial inflammation in response to inflammatory and infectious stimuli. Mucosal Immunol (2012) 1.02
Elafin prevents lipopolysaccharide-induced AP-1 and NF-kappaB activation via an effect on the ubiquitin-proteasome pathway. J Biol Chem (2006) 1.00
Endogenous salivary inhibitors of human immunodeficiency virus. Arch Oral Biol (1999) 0.98
Secretory leukoprotease inhibitor: partnering alpha 1-proteinase inhibitor to combat pulmonary inflammation. Thorax (1996) 0.98
The C-terminal 26-residue peptide of serpin A1 is an inhibitor of HIV-1. Biochem Biophys Res Commun (2006) 0.97
A systems biology examination of the human female genital tract shows compartmentalization of immune factor expression. J Virol (2013) 0.97
Interaction of HIV-1 and human salivary mucins. J Acquir Immune Defic Syndr (1994) 0.96
Oral HIV-exposure elicits mucosal HIV-neutralizing antibodies in uninfected men who have sex with men. AIDS (2009) 0.95
The role of intestinal microbiota and the immune system. Eur Rev Med Pharmacol Sci (2013) 0.95
Cathepsin G, a neutrophil-derived serine protease, increases susceptibility of macrophages to acute human immunodeficiency virus type 1 infection. J Virol (2000) 0.95
Salivary peptidomics. Expert Rev Proteomics (2010) 0.94
Inhibition of interferon response by cystatin B: implication in HIV replication of macrophage reservoirs. J Neurovirol (2011) 0.94
Cystatin B associates with signal transducer and activator of transcription 1 in monocyte-derived and placental macrophages. Placenta (2009) 0.91
Inhibition of HIV infectivity by human saliva. Oral Dis (1997) 0.89
HIV replication in CD4+ T lymphocytes in the presence and absence of follicular dendritic cells: inhibition of replication mediated by α-1-antitrypsin through altered IκBα ubiquitination. J Immunol (2011) 0.89
Effects of cathelicidin and its fragments on three key enzymes of HIV-1. Peptides (2011) 0.89
Mucosal serpin A1 and A3 levels in HIV highly exposed sero-negative women are affected by the menstrual cycle and hormonal contraceptives but are independent of epidemiological confounders. Am J Reprod Immunol (2012) 0.89
New approaches to making the microenvironment of the female reproductive tract hostile to HIV. Am J Reprod Immunol (2011) 0.88
The role of serpins in vertebrate immunity. Tissue Antigens (2008) 0.87
Inhibition of HIV-1 IIIB and clinical isolates by human parotid, submandibular, sublingual and palatine saliva. Eur J Oral Sci (2002) 0.86
The role of serpin and cystatin antiproteases in mucosal innate immunity and their defense against HIV. Am J Reprod Immunol (2013) 0.85
Lactoferrin inhibits HIV-1 replication in vitro and exhibits synergy when combined with zidovudine. AIDS (1999) 0.84
Salivary basic proline-rich proteins are elevated in HIV-exposed seronegative men who have sex with men. AIDS (2012) 0.84
Orally exposed uninfected individuals have systemic anti-HIV responses associating with partners' viral load. AIDS (2010) 0.82
Inhibition of HIV-1 infection by human α-defensin-5, a natural antimicrobial peptide expressed in the genital and intestinal mucosae. PLoS One (2012) 0.82
HIV-1 exposed uninfected men who have sex with men have increased levels of salivary CC-chemokines associated with sexual behavior. AIDS (2010) 0.80
Host defense proteins derived from human saliva bind to Staphylococcus aureus. Infect Immun (2013) 0.80
Adherence of oral microorganisms to human parotid salivary proteins. Electrophoresis (1996) 0.79
IFN-γ renders human intestinal epithelial cells responsive to lipopolysaccharide of Vibrio cholerae by down-regulation of DMBT1. Comp Immunol Microbiol Infect Dis (2012) 0.77
Identification of salivary proteins inhibiting herpes simplex virus 1 replication. Oral Microbiol Immunol (1995) 0.77
Expression of the luteinizing hormone receptor (LHR) gene in ovine non-gonadal tissues during estrous cycle. Genet Mol Res (2012) 0.76
[Cystatin C--modulator of immune processes]. Przegl Lek (2010) 0.75